Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

IDH Inhibitors Offer New, Safer Option for Some Brain Tumors

May 25th 2025, 6:00pm

Video

IDH inhibitors, now FDA approved for lower-grade gliomas, yield fewer side effects than chemotherapy, said Dr. Ryan Merrell.

Study Reveals Distinct Outcomes in Younger Patients With Grade 3 Oligodendroglioma

May 19th 2025, 1:00pm

Article

Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients, a study found.

Brain Cancer Awareness Month Highlights Advances in Radiation Therapy

May 16th 2025, 7:01pm

Article

Dr. Ranjit S. Bindra discusses recent advancements for the treatment of patients with primary brain tumors during Brain Cancer Awareness Month.

Advances in Radiation Improve Precision in Brain Cancer Therapy

May 12th 2025, 8:00pm

Video

The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton and carbon therapy.

Danyelza Added to NCCN Guidelines for High-Risk Neuroblastoma

May 8th 2025, 3:00pm

Article

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of brain cancer.

AI Tool Predicts Pediatric Glioma Recurrence With Up to 89% Accuracy

May 5th 2025, 4:00pm

Article

An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming single-image methods.

Larger Tumor Size Linked to Higher Mortality Risk in Brain Cancer

April 30th 2025, 3:18pm

Article

Investigators shared real-world data showing a clear and consistent association between increased tumor size and mortality for patients with brain cancer.

FDA Grants Breakthrough Status to CAR-T Therapy for Pediatric Brain Tumor

April 23rd 2025, 2:59pm

Article

The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma.

Support Patient Access and Education with the End Brain Cancer Initiative for GiveBIG 2025

April 22nd 2025, 5:40pm

Article

People can help EBCI reach their goal of $20,000 dollars raised for GiveBIG 2025 by giving at endbraincancer.org/donate.

TLX101 Demonstrated Efficacy in Recurrent High-Grade Glioma

April 16th 2025, 7:00pm

Article

TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from the phase 2 IPAX-Linz study.